Rhythm Pharmaceuticals announced a 29% increase in Q3 2026 net product revenue to $92.1 million, driven by strong U.S. sales of IMCIVREE for acquired hypothalamic obesity and ongoing launches in Japan and Canada. The company is progressing clinical trials for bivamelagon in Prader-Willi syndrome and acquired hypothalamic obesity, while securing a $750 million loan facility to support growth. Rhythm expects continued expansion in Europe and further clinical milestones in 2027, positioning it for long-term growth in rare neuroendocrine disease treatments.
Rhythm Pharmaceuticals' Q3 2026 results provide context for readers. On Pluang, 74 of 150 health-sector US stocks rose and 69 fell today. Notable movers include NBIX at USD 154.08 (+6.01%), PHG at USD 29.23 (+5.94%), and INO at USD 1.78 (-5.56%). Data is as of Nov 03, 2026 19:02 WIB.
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...
Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...
Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...
Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...
Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...
